Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Shares Outstanding (2016 - 2026)

Champions Oncology has reported Shares Outstanding over the past 16 years, most recently at $13.9 million for Q1 2026.

  • Quarterly results put Shares Outstanding at $13.9 million for Q1 2026, changed 0.44% from a year ago — trailing twelve months through Jan 2026 was $13.9 million (changed 0.44% YoY), and the annual figure for FY2025 was $13.8 million, changed 0.46%.
  • Shares Outstanding for Q1 2026 was $14.0 million at Champions Oncology, roughly flat from $14.0 million in the prior quarter.
  • Over the last five years, Shares Outstanding for CSBR hit a ceiling of $14.0 million in Q1 2026 and a floor of $13.5 million in Q3 2023.
  • Median Shares Outstanding over the past 5 years was $13.6 million (2023), compared with a mean of $13.7 million.
  • Biggest five-year swings in Shares Outstanding: fell 0.28% in 2023 and later grew 1.71% in 2025.
  • Champions Oncology's Shares Outstanding stood at $13.6 million in 2022, then increased by 0.26% to $13.6 million in 2023, then increased by 1.66% to $13.8 million in 2024, then grew by 1.36% to $14.0 million in 2025, then decreased by 0.86% to $13.9 million in 2026.
  • The last three reported values for Shares Outstanding were $13.9 million (Q1 2026), $14.0 million (Q4 2025), and $13.9 million (Q3 2025) per Business Quant data.